Letters
Phase I studies
Phase I studies: the role of publicly funded academic-healthcare partnerships
BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h3889 (Published 22 July 2015) Cite this as: BMJ 2015;351:h3889
- Nathan J Brendish, clinical research fellow1,
- Diane F Gbesemete, clinical research fellow1,
- Hans de Graaf, clinical research fellow1,
- Christopher J Edwards, director1,
- Saul N Faust, director1
- 1Southampton National Institute for Health Research Wellcome Trust Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton General Hospital, Southampton SO16 6YD, UK
- nathan.brendish{at}uhs.nhs.uk
Emanuel and colleagues’ meta-analysis found that phase I studies are very safe.1 However, the accompanying editorial mentioned that phase I studies are a “secret realm” and that “most studies are conducted outside academic medical centres at private facilities run by pharmaceutical companies or contract research organisations.” …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.